An additional measure for quantifying antibiotic use in hospitals

被引:69
作者
Filius, PMG
Liem, TBY
van der Linden, PD
Janknegt, R
Natsch, S
Vulto, AG
Verbrugh, HA
机构
[1] Univ Med Ctr Rotterdam, Erasmus MC, Dept Med Microbiol & Infect Dis, NL-3015 GD Rotterdam, Netherlands
[2] Univ Med Ctr Rotterdam, Erasmus MC, Dept Hosp Pharm, NL-3015 GD Rotterdam, Netherlands
[3] Apotheek Haagse Ziekenhuizen, Dept Pharm, The Hague, Netherlands
[4] Maasland Ziekenhuis, Dept Clin Pharm & Toxicol, Sittard, Netherlands
[5] Univ Med Ctr Nijmegen, Dept Clin Pharm, Nijmegen, Netherlands
[6] Univ Nijmegen, Ctr Infect Dis, Nijmegen, Netherlands
关键词
antibiotic usage; defined daily doses; selection density; selection pressure;
D O I
10.1093/jac/dki093
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The number of defined daily doses (DDD) per 100 patient days is often used as an indicator for the selection pressure exerted by antibiotics in the hospital setting. However, this unit of measurement does not fully describe the selection pressure and is sensitive to changes in hospital resource indicators. Additional information is required to facilitate interpretation of this indicator. The number of DDD per 100 admissions could be a valuable additional tool. The aim of this study is to investigate the importance of units of measurement in quantifying antibiotic use data with regards to antibiotic resistance risks. Patients and methods: Trends in antibiotic use in acute care Dutch hospitals between 1997-2001 were studied. Antibiotic use was expressed in DDD per 100 patient days and in DDD per 100 admissions. Results: From 1997 to 2001, total systemic antibiotic use significantly increased from 47.2 to 54.7 DDD per 100 patient days, whereas expressed in DDD per 100 admissions it remained constant. Some individual antibiotics increases in DDD per 100 patient days were not accompanied by increases in DDD per 100 admissions and vice versa. The mean number of total DDD per hospital decreased (not significantly) between 1997 and 2001. The mean number of patient days, admissions and length of stay decreased significantly. Conclusions: Knowledge of variation in resource indicators and additional expression of the data in DDD per 100 admissions is imperative for a meaningful understanding of observed trends in antibiotic use expressed in DDD per 100 patient days. Further research is needed to determine the correlation between different measures of antibiotic use and the level of antibiotic resistance.
引用
收藏
页码:805 / 808
页数:4
相关论文
共 12 条
[1]  
[Anonymous], 2003, The use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark
[2]   Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species [J].
Cosgrove, SE ;
Kaye, KS ;
Eliopoulous, GM ;
Carmeli, Y .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (02) :185-190
[3]   Development of a prescribing indicator for objective quantification of antibiotic usage in secondary care [J].
Curtis, C ;
Marriott, J ;
Langley, C .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (02) :529-533
[4]   Antibiotic resistance: Consequences of inaction [J].
Levy, SB .
CLINICAL INFECTIOUS DISEASES, 2001, 33 :S124-S129
[5]   Methodological validation of monitoring indicators of antibiotics use in hospitals [J].
Mandy, B ;
Koutny, E ;
Cornette, C ;
Woronoff-Lemsi, MC ;
Talon, D .
PHARMACY WORLD & SCIENCE, 2004, 26 (02) :90-95
[6]   Defined daily doses of antimicrobials reflect antimicrobial prescriptions in ambulatory care [J].
Monnet, DL ;
Mölstad, S ;
Cars, O .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (06) :1109-1111
[7]  
*NORM NORM VET, 2002, CONS ANT AG OCC RES
[8]   Antimicrobial use and resistance [J].
Michael A. Rubin ;
Matthew H. Samore .
Current Infectious Disease Reports, 2002, 4 (6) :491-497
[9]   Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage -: A randomized trial [J].
Schrag, SJ ;
Peña, C ;
Fernández, J ;
Sánchez, J ;
Gómez, V ;
Pérez, E ;
Feris, JM ;
Besser, RE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :49-56
[10]  
*SWAB, 2004, NETHMAP 2004 CONS AN